Medline Inc. Plans to Offer 75 Million Shares
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy MDLN?
Source: Benzinga
- Offering Size: Medline Inc. is set to offer 75 million shares of its Class A common stock, aiming to raise $3.4 billion, with pricing expected post-market on Wednesday, indicating sustained market demand for medical supply chains.
- Key Shareholder Participation: Major shareholders including Blackstone, Carlyle Group, Hellman and Friedman LLC, and Abu Dhabi Investment Authority are each offering shares, with Blackstone, Carlyle, and Hellman each contributing 23.3 million shares and ADIA 5.1 million shares, reflecting investor confidence in Medline's future growth.
- Underwriter Lineup: Top investment banks such as Morgan Stanley, Bank of America, JPMorgan Chase, and Goldman Sachs are involved in the offering, showcasing strong market interest in Medline and providing investors with diversified investment options.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions globally, operating 30 manufacturing facilities and 70 distribution centers with a workforce of 45,000; despite a recent 4.6% stock decline, the stock has risen nearly 7% year-to-date.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MDLN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MDLN
Wall Street analysts forecast MDLN stock price to rise
14 Analyst Rating
13 Buy
1 Hold
0 Sell
Strong Buy
Current: 44.390
Low
42.00
Averages
47.92
High
52.00
Current: 44.390
Low
42.00
Averages
47.92
High
52.00
About MDLN
Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Medline Inc. Plans to Offer 75 Million Shares
- Offering Size: Medline Inc. is set to offer 75 million shares of its Class A common stock, aiming to raise $3.4 billion, with pricing expected post-market on Wednesday, indicating sustained market demand for medical supply chains.
- Key Shareholder Participation: Major shareholders including Blackstone, Carlyle Group, Hellman and Friedman LLC, and Abu Dhabi Investment Authority are each offering shares, with Blackstone, Carlyle, and Hellman each contributing 23.3 million shares and ADIA 5.1 million shares, reflecting investor confidence in Medline's future growth.
- Underwriter Lineup: Top investment banks such as Morgan Stanley, Bank of America, JPMorgan Chase, and Goldman Sachs are involved in the offering, showcasing strong market interest in Medline and providing investors with diversified investment options.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions globally, operating 30 manufacturing facilities and 70 distribution centers with a workforce of 45,000; despite a recent 4.6% stock decline, the stock has risen nearly 7% year-to-date.
See More
Medline Shareholders Launch Public Offering of 75M Shares
- Shareholder Offering: Shareholders including Blackstone, Carlyle, Hellman & Friedman, and a unit of Abu Dhabi Investment Authority are launching a public offering of 75 million shares of Medline's Class A stock, causing the company's shares to drop over 5% in premarket trading.
- Additional Stock Option: The selling stockholders intend to grant underwriters a 30-day option to purchase an additional 11.25 million shares of Medline's Class A common stock, which could further dilute existing shareholders' stakes.
- Company's Non-Participation: Medline is not selling any Class A common stock in this offering and will not receive any proceeds, indicating a conservative approach to capital market financing.
- Market Reaction Analysis: The stock price decline triggered by this public offering reflects market sensitivity to shareholder sell-offs, potentially impacting investor confidence in Medline's future growth prospects.
See More
Medline Reports Mixed Q4 Results with Strong Sales but Earnings Miss
- Earnings Overview: Medline Inc reported a quarterly loss of $0.01 per share, missing the analyst consensus estimate of $0.18 per share, indicating pressure on profitability.
- Sales Performance: The company achieved quarterly sales of $7.787 billion, exceeding the analyst consensus estimate of $7.547 billion, demonstrating strong market demand and reinforcing its position in the healthcare sector.
- Customer Signing Update: CEO Jim Boyle noted that total new customer signings reached $2.4 billion for 2025, reflecting customer confidence in Medline's value, service, and reliability, enhancing the company's capability to support health systems.
- Stock Price Reaction: Following the earnings announcement, Medline's shares rose by 3.4% to $49.80, indicating market optimism regarding the company's future prospects.
See More
Medline Inc. Raises $6.26 Billion in Successful IPO
- Earnings Report: Medline Inc.'s Q4 results reveal a GAAP EPS of -$0.01, missing expectations by $0.14, while revenue reached $7.8 billion, up 14.8% year-over-year, exceeding forecasts by $290 million, indicating robust market performance.
- Growth Drivers: The revenue increase was primarily driven by strong growth in both the Medline Brand and Supply Chain Solutions segments, highlighting sustained demand in the medical supply sector and enhancing the company's competitive position.
- Future Outlook: The company anticipates organic sales growth of 8% to 9% for 2026, with adjusted EBITDA projected between $3.5 billion and $3.6 billion, reflecting management's confidence in future performance and ongoing growth potential.
- Successful IPO: Medline Inc. successfully raised $6.26 billion in its IPO at a price of $29 per share, with the stock surging 28%, demonstrating strong market confidence in its business model and growth prospects.
See More
Stock Movers: Nvidia, Paramount, First Solar, Workday, Axon, HP Inc., Lucid, and Others
- Stock Market Movement: Stock futures were rising on Wednesday, indicating positive investor sentiment.
- Response to Political Events: Investors appeared to overlook President Donald Trump’s State of the Union address, focusing instead on market trends.
See More
Medline Inc. Raises $6.26 Billion in Successful IPO
- Strong IPO Performance: Medline Inc. successfully raised $6.26 billion in its IPO by pricing shares at $29 each, reflecting strong market confidence in its business model and providing ample funding for future expansion.
- High Market Demand: The IPO attracted significant investor interest, with shares surging 28% upon opening, indicating strong recognition of Medline's growth potential and profitability in the medical supply sector, which may further enhance its market share.
- Earnings Forecast: Medline is set to announce its Q4 earnings on February 25, with consensus estimates predicting an EPS of $0.24 and revenue of $7.51 billion, providing crucial insights into the company's financial health for investors.
- Strengthened Industry Position: Medline boasts a solid physical moat in the medical supply industry, and with visible earnings growth, the company is poised for sustained market expansion and revenue growth in the coming years.
See More
Medline Inc. Plans to Offer 75 Million Shares
- Offering Size: Medline Inc. is set to offer 75 million shares of its Class A common stock, aiming to raise $3.4 billion, with pricing expected post-market on Wednesday, indicating sustained market demand for medical supply chains.
- Key Shareholder Participation: Major shareholders including Blackstone, Carlyle Group, Hellman and Friedman LLC, and Abu Dhabi Investment Authority are each offering shares, with Blackstone, Carlyle, and Hellman each contributing 23.3 million shares and ADIA 5.1 million shares, reflecting investor confidence in Medline's future growth.
- Underwriter Lineup: Top investment banks such as Morgan Stanley, Bank of America, JPMorgan Chase, and Goldman Sachs are involved in the offering, showcasing strong market interest in Medline and providing investors with diversified investment options.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions globally, operating 30 manufacturing facilities and 70 distribution centers with a workforce of 45,000; despite a recent 4.6% stock decline, the stock has risen nearly 7% year-to-date.
See More
Medline Shareholders Launch Public Offering of 75M Shares
- Shareholder Offering: Shareholders including Blackstone, Carlyle, Hellman & Friedman, and a unit of Abu Dhabi Investment Authority are launching a public offering of 75 million shares of Medline's Class A stock, causing the company's shares to drop over 5% in premarket trading.
- Additional Stock Option: The selling stockholders intend to grant underwriters a 30-day option to purchase an additional 11.25 million shares of Medline's Class A common stock, which could further dilute existing shareholders' stakes.
- Company's Non-Participation: Medline is not selling any Class A common stock in this offering and will not receive any proceeds, indicating a conservative approach to capital market financing.
- Market Reaction Analysis: The stock price decline triggered by this public offering reflects market sensitivity to shareholder sell-offs, potentially impacting investor confidence in Medline's future growth prospects.
See More
Medline Reports Mixed Q4 Results with Strong Sales but Earnings Miss
- Earnings Overview: Medline Inc reported a quarterly loss of $0.01 per share, missing the analyst consensus estimate of $0.18 per share, indicating pressure on profitability.
- Sales Performance: The company achieved quarterly sales of $7.787 billion, exceeding the analyst consensus estimate of $7.547 billion, demonstrating strong market demand and reinforcing its position in the healthcare sector.
- Customer Signing Update: CEO Jim Boyle noted that total new customer signings reached $2.4 billion for 2025, reflecting customer confidence in Medline's value, service, and reliability, enhancing the company's capability to support health systems.
- Stock Price Reaction: Following the earnings announcement, Medline's shares rose by 3.4% to $49.80, indicating market optimism regarding the company's future prospects.
See More
Medline Inc. Raises $6.26 Billion in Successful IPO
- Earnings Report: Medline Inc.'s Q4 results reveal a GAAP EPS of -$0.01, missing expectations by $0.14, while revenue reached $7.8 billion, up 14.8% year-over-year, exceeding forecasts by $290 million, indicating robust market performance.
- Growth Drivers: The revenue increase was primarily driven by strong growth in both the Medline Brand and Supply Chain Solutions segments, highlighting sustained demand in the medical supply sector and enhancing the company's competitive position.
- Future Outlook: The company anticipates organic sales growth of 8% to 9% for 2026, with adjusted EBITDA projected between $3.5 billion and $3.6 billion, reflecting management's confidence in future performance and ongoing growth potential.
- Successful IPO: Medline Inc. successfully raised $6.26 billion in its IPO at a price of $29 per share, with the stock surging 28%, demonstrating strong market confidence in its business model and growth prospects.
See More
Stock Movers: Nvidia, Paramount, First Solar, Workday, Axon, HP Inc., Lucid, and Others
- Stock Market Movement: Stock futures were rising on Wednesday, indicating positive investor sentiment.
- Response to Political Events: Investors appeared to overlook President Donald Trump’s State of the Union address, focusing instead on market trends.
See More
Medline Inc. Raises $6.26 Billion in Successful IPO
- Strong IPO Performance: Medline Inc. successfully raised $6.26 billion in its IPO by pricing shares at $29 each, reflecting strong market confidence in its business model and providing ample funding for future expansion.
- High Market Demand: The IPO attracted significant investor interest, with shares surging 28% upon opening, indicating strong recognition of Medline's growth potential and profitability in the medical supply sector, which may further enhance its market share.
- Earnings Forecast: Medline is set to announce its Q4 earnings on February 25, with consensus estimates predicting an EPS of $0.24 and revenue of $7.51 billion, providing crucial insights into the company's financial health for investors.
- Strengthened Industry Position: Medline boasts a solid physical moat in the medical supply industry, and with visible earnings growth, the company is poised for sustained market expansion and revenue growth in the coming years.
See More
